Stocks
Catalent, Inc.

Catalent, Inc.CTLT

NYSEHealthcareBiotechnology$63.48+0.00%

Price as of · delayed, not real-time

A leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Catalent is a key partner for pharmaceutical companies seeking to accelerate development and improve manufacturing efficiency, making it a closely watched stock in the biopharma services space.

Market Cap: $11.5B52W Range: $42.11-$63.50

Congressional Interest in Catalent, Inc. (CTLT)

9 members of Congress have disclosed 44 trades in Catalent, Inc. (CTLT), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 28 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
44
Unique Politicians
9
Buys
16
Sells
28

Who in Congress Is Trading CTLT?

2024-08-02$1K-$15K
Stock
2024-04-25$1K-$15K
Stock
2024-02-13$1K-$15K
Stock
2023-03-07$1K-$15K
Stock
2022-11-30$1K-$15K
Stock
2022-11-21$1K-$15K
Stock
2022-11-03$1K-$15K
Stock
2022-05-04$1K-$15K
Stock
2021-06-03$1K-$15K
Stock
2021-01-06$1K-$15K
Stock
2020-12-18$1K-$15K
Stock
2020-10-15$1K-$15K
Stock
2020-09-29$1K-$15K
Stock
2020-09-24$1K-$15K
Stock
2020-09-02$1K-$15K
Stock
2020-08-17$1K-$15K
Stock
2020-08-12$1K-$15K
Stock
2020-08-03$1K-$15K
Stock
2020-08-03$1K-$15K
Stock
2020-06-19$1K-$15K
Stock
2020-06-01$1K-$15K
Stock
2020-05-28$1K-$15K
Stock
2020-05-27$1K-$15K
Stock
2020-05-19$1K-$15K
Stock
2020-05-19$1K-$15K
Stock
2020-05-15$1K-$15K
Stock
2020-05-15$1K-$15K
Stock
2020-05-15$1K-$15K
Stock
2020-05-06$1K-$15K
Stock
2020-03-27$1K-$15K
Stock
2020-03-16$1K-$15K
Stock
2020-02-06$1K-$15K
Stock
2020-02-04$1K-$15K
Stock
2020-02-03$1K-$15K
Stock
2020-01-06$1K-$15K
Stock
2019-11-29$1K-$15K
Stock
2019-11-27$1K-$15K
Stock
2019-11-26$1K-$15K
Stock
2019-10-08$1K-$15K
Stock
2019-02-27$1K-$15K
Stock
2017-12-18$1K-$15K
Stock
2016-08-04$1K-$15K
Stock
2015-12-15$1K-$15K
Stock
2015-07-07$15K-$50K
Stock